Transplantation ChimeraChimeraLiver TransplantationTransplantation, HomologousKidney TransplantationBone Marrow TransplantationHematopoietic Stem Cell TransplantationHeart TransplantationTransplantation, AutologousLung TransplantationStem Cell TransplantationTransplantation ConditioningOrgan TransplantationGraft SurvivalGraft RejectionPancreas TransplantationIslets of Langerhans TransplantationTissue DonorsTransplantation ImmunologyTransplantationCell TransplantationRadiation ChimeraImmunosuppressive AgentsGraft vs Host DiseaseTransplantation, IsogeneicTreatment OutcomeLiving DonorsTransplantation, HeterotopicCord Blood Stem Cell TransplantationHeart-Lung TransplantationTransplantation ToleranceTissue and Organ ProcurementTime FactorsFetal Tissue TransplantationPeripheral Blood Stem Cell TransplantationRetrospective StudiesSkin TransplantationImmunosuppressionLiver FailureHistocompatibility TestingRecombinant Fusion ProteinsPostoperative ComplicationsTransplantation, HeterologousFocus GroupsWaiting ListsRecurrenceHistocompatibilityMesenchymal Stem Cell TransplantationTissue TransplantationWhole-Body IrradiationCorneal TransplantationHematologic NeoplasmsTacrolimusCyclosporineFollow-Up StudiesCadaverSurvival AnalysisSurvival RateBrain Tissue TransplantationMice, Inbred C57BLDonor SelectionLiver DiseasesFacial TransplantationTransplantsOrgan PreservationBusulfanMolecular Sequence DataHLA AntigensLeukemiaKidney Failure, ChronicRisk FactorsHematopoietic Stem CellsCombined Modality TherapyBronchiolitis ObliteransT-LymphocytesCell DifferentiationLiverAntilymphocyte SerumChimerismAcute DiseaseBone Marrow CellsHand TransplantationRemission InductionCytomegalovirus InfectionsAnemia, AplasticBlood Group IncompatibilityPostoperative PeriodMycophenolic AcidMyeloablative AgonistsPrognosisAmino Acid SequenceTissue and Organ HarvestingRats, Inbred LewCyclophosphamideNeoplasm TransplantationEnd Stage Liver DiseasePatient SelectionStem CellsCells, CulturedGraft vs Leukemia Effect